bf/NASDAQ:ALNY_icon.jpeg

COM:ALNYLAM

Alnylam Pharmaceuticals

  • Stock

Last Close

248.79

21/11 21:00

Market Cap

32.60B

Beta: -

Volume Today

676.38K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-89.22M
-
-360.39M
303.92%
-290.07M
19.51%
-410.11M
41.38%
-490.87M
19.69%
-761.50M
55.13%
-886.12M
16.37%
-858.28M
3.14%
-852.82M
0.64%
-1.13B
32.64%
-440.24M
61.08%
depreciation and amortization
10.23M
-
11.93M
16.59%
19.05M
59.74%
15.13M
20.58%
13.37M
11.65%
6.43M
51.86%
54.37M
744.88%
74.44M
36.91%
89.69M
20.50%
85.55M
4.62%
54.05M
36.82%
deferred income tax
-2.69M
-
-42.29M
1,469.20%
-6.98M
-
1.89M
127.15%
-3.56M
288.17%
-11.29M
216.72%
-54.04M
378.76%
-55.70M
3.06%
-399.36M
-
stock based compensation
20.70M
-
33.06M
59.69%
45.78M
38.48%
75.53M
64.97%
92.82M
22.89%
157.75M
69.96%
174.84M
10.83%
139.87M
20.00%
165.72M
18.48%
230.65M
39.18%
221.68M
3.89%
change in working capital
-8.12M
-
-29.40M
262.17%
35.12M
219.44%
17.22M
50.97%
-2.90M
116.85%
45.10M
1,654.07%
402.38M
792.22%
-12.70M
103.16%
-162.82M
1,181.97%
-35.55M
78.16%
10.76M
130.26%
accounts receivables
-4.14M
-
-35.69M
761.22%
31.64M
188.65%
-15.04M
147.52%
-10.67M
29.05%
15.24M
242.88%
-24.24M
259.02%
-56.24M
132.02%
-101.80M
81.02%
-45.60M
55.21%
-87.94M
92.86%
inventory
191K
-
3.29M
1,624.08%
-477K
114.49%
5.40M
1,231.45%
10.86M
101.17%
-22.64M
308.58%
-32.41M
43.13%
-35.43M
9.30%
-26.41M
25.44%
-34.14M
29.23%
18.37M
153.81%
accounts payables
1.83M
-
8.84M
382.53%
1.68M
81.04%
10.10M
502.51%
-4.94M
148.91%
15.48M
413.38%
36.61M
136.52%
117.38M
220.62%
88.24M
24.82%
191.77M
117.33%
80.84M
57.85%
other working capital
-6.00M
-
-5.84M
2.53%
2.28M
138.97%
16.76M
635.73%
1.85M
88.97%
37.02M
1,903.46%
422.42M
1,040.94%
-38.41M
109.09%
-122.85M
219.79%
-147.59M
20.14%
-509K
99.66%
other non cash items
449K
-
221.46M
49,222.49%
984K
99.56%
1.51M
53.15%
2.91M
93.10%
-6.84M
335.09%
-12.61M
84.37%
95.75M
859.18%
174.24M
81.96%
309.24M
77.48%
657.26M
112.54%
net cash provided by operating activities
-68.66M
-
-165.64M
141.26%
-189.14M
14.19%
-307.70M
62.68%
-382.79M
24.40%
-562.62M
46.98%
-278.43M
50.51%
-614.96M
120.87%
-641.69M
4.35%
-541.27M
15.65%
104.16M
119.24%
investments in property plant and equipment
-4.01M
-
-8.96M
123.69%
-12.95M
44.52%
-64.56M
398.51%
-104.21M
61.42%
-126.89M
21.76%
-140.16M
10.46%
-70.36M
49.80%
-76.37M
8.54%
-72.06M
5.65%
-62.21M
13.67%
acquisitions net
purchases of investments
-364.31M
-
-977.77M
168.39%
-1.03B
5.73%
-759.31M
26.55%
-903.46M
18.98%
-1.10B
22.20%
-2.08B
88.03%
-2.03B
2.42%
-1.66B
18.24%
-1.98B
19.37%
-1.88B
4.80%
sales maturities of investments
237.81M
-
462.92M
94.66%
726.94M
57.03%
1.12B
53.58%
597.30M
46.50%
1.52B
154.26%
1.78B
16.90%
1.69B
4.72%
1.46B
13.48%
2.23B
52.48%
1.61B
27.75%
other investing activites
-25M
-
-1.47M
94.12%
-150M
10,097.14%
120M
180%
-14.82M
112.35%
23M
255.14%
-31.20M
235.65%
-4.36M
86.01%
-13.19M
202.34%
-4.44M
66.36%
net cash used for investing activites
-130.50M
-
-548.81M
320.53%
-321.32M
41.45%
142.59M
144.38%
-290.36M
303.63%
272.94M
194.00%
-417.68M
253.03%
-435.52M
4.27%
-273.30M
37.25%
169.35M
161.97%
-336.35M
298.61%
debt repayment
-120M
-
-30M
-
-686.60M
2,188.66%
-1B
45.65%
-762.11M
23.79%
common stock issued
173.57M
-
723.04M
316.56%
585.42M
19.03%
14.30M
97.56%
1.16B
8,018.36%
781.90M
-
99.50M
87.27%
246.27M
147.51%
259.36M
5.32%
147.46M
43.14%
common stock repurchased
-1.39M
-
-15.99M
1,051.33%
-378K
97.64%
-596K
57.67%
-257K
56.88%
-3.47M
1,249.81%
dividends paid
other financing activites
28.74M
-
29.42M
2.36%
31.14M
5.84%
164.13M
427.11%
84.14M
48.73%
68.94M
18.07%
71.28M
3.40%
1.58B
2,119.40%
2.00B
26.47%
928.50M
53.59%
24.67M
97.34%
net cash used provided by financing activities
200.93M
-
736.47M
266.54%
616.18M
16.33%
177.83M
71.14%
1.12B
532.56%
65.47M
94.18%
823.18M
1,157.35%
994.98M
20.87%
1.25B
25.34%
425.75M
65.86%
172.13M
59.57%
effect of forex changes on cash
-83K
-
4.92M
6,025.30%
-9.02M
283.37%
-7.43M
17.61%
6.39M
186.02%
net change in cash
1.76M
-
22.01M
1,147.73%
105.72M
380.31%
12.72M
87.97%
451.74M
3,450.89%
-224.20M
149.63%
127.00M
156.64%
-50.58M
139.83%
323.11M
738.78%
46.40M
85.64%
-53.71M
215.74%
cash at beginning of period
51.41M
-
53.17M
3.43%
75.18M
41.40%
180.90M
140.62%
193.62M
7.03%
646.83M
234.08%
422.63M
34.66%
549.63M
30.05%
499.05M
9.20%
822.15M
64.74%
866.39M
5.38%
cash at end of period
53.17M
-
75.18M
41.40%
180.90M
140.62%
193.62M
7.03%
645.36M
233.32%
422.63M
34.51%
549.63M
30.05%
499.05M
9.20%
822.15M
64.74%
868.56M
5.64%
812.69M
6.43%
operating cash flow
-68.66M
-
-165.64M
141.26%
-189.14M
14.19%
-307.70M
62.68%
-382.79M
24.40%
-562.62M
46.98%
-278.43M
50.51%
-614.96M
120.87%
-641.69M
4.35%
-541.27M
15.65%
104.16M
119.24%
capital expenditure
-4.01M
-
-8.96M
123.69%
-12.95M
44.52%
-64.56M
398.51%
-104.21M
61.42%
-126.89M
21.76%
-140.16M
10.46%
-70.36M
49.80%
-76.37M
8.54%
-72.06M
5.65%
-62.21M
13.67%
free cash flow
-72.66M
-
-174.60M
140.29%
-202.09M
15.74%
-372.26M
84.20%
-487.00M
30.82%
-689.50M
41.58%
-418.58M
39.29%
-685.32M
63.72%
-718.07M
4.78%
-613.33M
14.59%
41.95M
106.84%

All numbers in (except ratios and percentages)